medical-marijuana-inc-portfolio-investment-company-kannalife-inc-receives-patent-in-australia-for-its-novel-monotherapeutic-compounds-to-treat-cns-and-pns-disorders.jpg

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders